Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. Reduced monthly costs for uninsured patients still amount to around ...

The urgent directive follows alarming findings by Lancet, the British medical journal, that projected a surge in overweight ...